147 related articles for article (PubMed ID: 25843269)
1. The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China.
Wang F; Shen L; Cui F; Zhang S; Zheng H; Zhang Y; Liang X; Wang F; Bi S
Vaccine; 2015 May; 33(23):2704-9. PubMed ID: 25843269
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China.
Shen L; Wang F; Wang F; Cui F; Zhang S; Zheng H; Zhang Y; Liang X; Bi S
Vaccine; 2012 Oct; 30(47):6623-7. PubMed ID: 22959987
[TBL] [Abstract][Full Text] [Related]
3. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
4. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?
Li H; Li GJ; Chen QY; Fang ZL; Wang XY; Tan C; Yang QL; Wang FZ; Wang F; Zhang S; Bi SL; Shen LP
Epidemiol Infect; 2017 Apr; 145(5):887-894. PubMed ID: 28065199
[TBL] [Abstract][Full Text] [Related]
7. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
8. The long-term efficacy of Chinese hamster ovary cell derived hepatitis B vaccine after being used for 14-16 years in Chinese rural communities.
Wang F; Ma J; Hao Z; Zhang Z; Zhang X; Gao Z; Bi S; Shen L; Qiu F; Zhao Y
Vaccine; 2015 Jan; 33(2):294-7. PubMed ID: 25454089
[TBL] [Abstract][Full Text] [Related]
9. [Study on the variations of hepatitis B virus status among people having received hepatitis B vaccine].
Shen LP; Yang JY; Mo ZJ; Li RC; Li YP; Wei ZL; Dong YH; Zhou KJ; Wei SC; Fang KX; Yu T; Zhang WY; Zhang Y; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jul; 28(7):659-62. PubMed ID: 18069553
[TBL] [Abstract][Full Text] [Related]
10. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
[TBL] [Abstract][Full Text] [Related]
11. [Variations of hepatitis B virus infection epidemic pattern after long-term HBV vaccine immunization].
Shen LP; Yang JY; Mo ZJ; Li RC; Li YP; Wei ZL; Dong YH; Zhou KJ; Wei SC; Fang KX; Yu T; Zhang WY; Zhang Y; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):253-5. PubMed ID: 17971937
[TBL] [Abstract][Full Text] [Related]
12. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme.
Shen LP; Zhang Y; Wang F; Zhang S; Yang JY; Fang KX; Yu T; Wang XY; Zhang WY; Bi SL
Epidemiol Infect; 2011 Aug; 139(8):1159-65. PubMed ID: 21156099
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
Kao JT; Wang JH; Hung CH; Yen YH; Hung SF; Hu TH; Lee CM; Lu SN
Vaccine; 2009 Mar; 27(12):1858-62. PubMed ID: 19186203
[TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis B vaccination among children in Guangdong Province, China.
Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
[TBL] [Abstract][Full Text] [Related]
16. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
Yang W; Liang X; Cui F; Li L; Hadler SC; Hutin YJ; Kane M; Wang Y
Vaccine; 2013 Dec; 31 Suppl 9():J73-8. PubMed ID: 24331024
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China.
Wang Y; Shi JF; Wang L; Yan Y; Yao H; Dai M; Chen T; Qu C
Int J Infect Dis; 2019 Jan; 78():130-139. PubMed ID: 30466898
[TBL] [Abstract][Full Text] [Related]
18. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
19. [Study on the efficacy of hepatitis B virus vaccination and its influencing factors among children in rural area of Jiangsu province].
Zhai XJ; Wang H; Zhu FC; Yu JX; Chen YZ; Qiu XP; Gu SK; Liu SL; Qin LM; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):322-5. PubMed ID: 17850694
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.
Rey-Cuille MA; Njouom R; Bekondi C; Seck A; Gody C; Bata P; Garin B; Maylin S; Chartier L; Simon F; Vray M
Pediatr Infect Dis J; 2013 Oct; 32(10):1110-5. PubMed ID: 23694839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
